EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN
The article is dedicated to the use of immunomodulators in children, conditions, at which the prescription of this group of drugs is reasonable, action mechanism and also efficacy are given. In particular, the authors give their observation results for a group of HPV-infected children vaccinated by...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2013-01-01
|
| Series: | Педиатрическая фармакология |
| Subjects: | |
| Online Access: | https://www.pedpharma.ru/jour/article/view/255 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849404660085948416 |
|---|---|
| author | A. A. Ruleva S. M. Kharit E. P. Nacharova I. V. Fridman |
| author_facet | A. A. Ruleva S. M. Kharit E. P. Nacharova I. V. Fridman |
| author_sort | A. A. Ruleva |
| collection | DOAJ |
| description | The article is dedicated to the use of immunomodulators in children, conditions, at which the prescription of this group of drugs is reasonable, action mechanism and also efficacy are given. In particular, the authors give their observation results for a group of HPV-infected children vaccinated by live vaccines (rubella and divalent measles-parotitis vaccine) together with pidotimod usage. No undesirable phenomena were registered in the postvaccinal period. Dynamics of immunological indicators did not change significantly. Seroconversion level of measles antibodies totaled 100% by the 30th observation day. |
| format | Article |
| id | doaj-art-9e2124ab8bab47e198cb126898581ff6 |
| institution | Kabale University |
| issn | 1727-5776 2500-3089 |
| language | Russian |
| publishDate | 2013-01-01 |
| publisher | Union of pediatricians of Russia |
| record_format | Article |
| series | Педиатрическая фармакология |
| spelling | doaj-art-9e2124ab8bab47e198cb126898581ff62025-08-20T03:36:54ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892013-01-01101707310.15690/pf.v10i1.591255EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDRENA. A. Ruleva0S. M. Kharit1E. P. Nacharova2I. V. Fridman3Research institute of children’s infections at the Federal Medical-Biological Agency, Saint Petersburg, Russian FederationResearch institute of children’s infections at the Federal Medical-Biological Agency, Saint Petersburg, Russian FederationResearch institute of children’s infections at the Federal Medical-Biological Agency, Saint Petersburg, Russian FederationResearch institute of children’s infections at the Federal Medical-Biological Agency, Saint Petersburg, Russian FederationThe article is dedicated to the use of immunomodulators in children, conditions, at which the prescription of this group of drugs is reasonable, action mechanism and also efficacy are given. In particular, the authors give their observation results for a group of HPV-infected children vaccinated by live vaccines (rubella and divalent measles-parotitis vaccine) together with pidotimod usage. No undesirable phenomena were registered in the postvaccinal period. Dynamics of immunological indicators did not change significantly. Seroconversion level of measles antibodies totaled 100% by the 30th observation day.https://www.pedpharma.ru/jour/article/view/255biologic response modifier therapyhivlive vaccineschildren |
| spellingShingle | A. A. Ruleva S. M. Kharit E. P. Nacharova I. V. Fridman EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN Педиатрическая фармакология biologic response modifier therapy hiv live vaccines children |
| title | EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN |
| title_full | EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN |
| title_fullStr | EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN |
| title_full_unstemmed | EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN |
| title_short | EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN |
| title_sort | efficiency and safety of using pidotimod in vaccinated risk group children |
| topic | biologic response modifier therapy hiv live vaccines children |
| url | https://www.pedpharma.ru/jour/article/view/255 |
| work_keys_str_mv | AT aaruleva efficiencyandsafetyofusingpidotimodinvaccinatedriskgroupchildren AT smkharit efficiencyandsafetyofusingpidotimodinvaccinatedriskgroupchildren AT epnacharova efficiencyandsafetyofusingpidotimodinvaccinatedriskgroupchildren AT ivfridman efficiencyandsafetyofusingpidotimodinvaccinatedriskgroupchildren |